- Home
- CSTM vs APLS Comparison
CSTM vs APLS Comparison
Compare CSTM & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTM
- APLS
- Stock Information
- Founded
- CSTM 2010
- APLS 2009
- Country
- CSTM France
- APLS United States
- Employees
- CSTM N/A
- APLS N/A
- Industry
- CSTM Metal Fabrications
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- CSTM Industrials
- APLS Health Care
- Exchange
- CSTM Nasdaq
- APLS Nasdaq
- Market Cap
- CSTM 1.9B
- APLS 2.2B
- IPO Year
- CSTM 2013
- APLS 2017
- Fundamental
- Price
- CSTM $14.24
- APLS $26.58
- Analyst Decision
- CSTM Buy
- APLS Buy
- Analyst Count
- CSTM 3
- APLS 20
- Target Price
- CSTM $18.00
- APLS $34.11
- AVG Volume (30 Days)
- CSTM 1.5M
- APLS 3.0M
- Earning Date
- CSTM 07-29-2025
- APLS 07-31-2025
- Dividend Yield
- CSTM N/A
- APLS N/A
- EPS Growth
- CSTM N/A
- APLS N/A
- EPS
- CSTM 0.22
- APLS N/A
- Revenue
- CSTM $7,605,000,000.00
- APLS $754,649,000.00
- Revenue This Year
- CSTM $5.41
- APLS $10.84
- Revenue Next Year
- CSTM $8.46
- APLS $10.51
- P/E Ratio
- CSTM $62.76
- APLS N/A
- Revenue Growth
- CSTM 2.04
- APLS 20.02
- 52 Week Low
- CSTM $7.33
- APLS $16.10
- 52 Week High
- CSTM $17.27
- APLS $41.94
- Technical
- Relative Strength Index (RSI)
- CSTM 56.48
- APLS 77.42
- Support Level
- CSTM $13.06
- APLS $23.75
- Resistance Level
- CSTM $14.01
- APLS $24.64
- Average True Range (ATR)
- CSTM 0.61
- APLS 1.29
- MACD
- CSTM -0.02
- APLS 0.38
- Stochastic Oscillator
- CSTM 50.00
- APLS 98.78
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.